Lumexa Imaging LMRI
$14.26 +$0.20 (+1.42%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $14.26 0.00%
Open$13.87
Prev close$14.06
Day range$13.87 – $14.47
Volume442.4K
Market cap$1.37B
P/E (TTM)–
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$271.97M+5.0% YoY
Operating profit$6.05M-53.4% YoY
Net profit$7.18M+305.0% YoY
Diluted EPS$0.07+289.1% YoY
Free cash flow$20.60M+1,266.7% YoY
Operating cash flow$34.81M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin15.4%
Operating margin0.7%
Net margin-1.6%
Return on equity-4.3%
Return on assets-1.0%
Return on invested capital1.9%
Current ratio1.52
Liabilities / assets65.4%
Cash & investments$90.01M
Total debt$949.55M
Net cash (debt)-$859.54M
Free cash flow / sales5.1%
Where the revenue comes from
Quarter 2026/Q2
By business line
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $271.97M | $264.16M | $252.54M | $1.02B | $267.73M |
| Total Operating Revenue | $271.97M | $264.16M | $252.54M | $1.02B | $267.73M |
| Cost of Revenue | $225.57M | $225.29M | $217.76M | $865.52M | $225.62M |
| Gross Profit | $46.40M | $38.88M | $34.78M | $157.57M | $42.12M |
| Operating Expense | $40.36M | $34.48M | $30.26M | $130.83M | $49.59M |
| Selling and Admin Expenses | $30.03M | $24.40M | $20.34M | $90.45M | $37.19M |
| -General & Admin Expense | $30.03M | $24.40M | $20.34M | $90.45M | $37.19M |
| Depreciation & Amortization & Depletion | $10.33M | $10.08M | $9.92M | $40.38M | $12.40M |
| -Depreciation & Amortization | $10.33M | $10.08M | $9.92M | $40.38M | $12.40M |
| Operating Profit | $6.05M | $4.40M | $4.53M | $26.73M | -$7.47M |
| Net Non-Operating Interest Income (Expense) | -$15.67M | -$16.22M | -$16.33M | -$118.54M | -$28.02M |
| Non-Operating Interest Expense | $15.67M | $16.22M | $16.33M | $118.54M | $28.02M |
| Other Income (Expense) | $21.41M | $17.59M | $14.89M | $59.59M | $10.23M |
| Earnings from Equity Interest | $22.85M | $18.62M | $15.02M | $72.14M | $22.30M |
| Special Income (Charges) | -$779,000.00 | -$1.03M | -$137,000.00 | -$14.42M | -$13.94M |
| -Gain on Sale of Property/Plant/Equipment | -$779,000.00 | $24,000.00 | -$137,000.00 | -$968,000.00 | -$491,000.00 |
| Other Non-Operating Income (Expenses) | -$654,000.00 | – | – | $1.87M | – |
| Pretax Profit | $11.79M | $5.77M | $3.08M | -$32.22M | -$25.26M |
| Tax | $4.61M | $3.02M | $1.36M | $14.89M | $3.43M |
| Net Profit | $7.18M | $2.75M | $1.72M | -$47.10M | -$28.69M |
| Profit from Continuing Operations | $7.18M | $2.75M | $1.72M | -$47.10M | -$28.69M |
| Net Income to Parent Company | $7.18M | $2.75M | $1.72M | -$47.10M | -$28.69M |
| Net Income to Common Stockholders | $7.18M | $2.75M | $1.72M | -$47.10M | -$28.69M |
| Basic EPS | $0.07 | $0.03 | $0.02 | -$0.66 | -$0.38 |
| Diluted EPS | $0.07 | $0.03 | $0.02 | -$0.66 | -$0.38 |
| -Less:Other Special Charges | – | $1.05M | – | $13.45M | – |
| -Less:Impairment of Capital Assets | – | – | – | $0.00 | – |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $1.83B | $1.81B | $1.76B | $1.76B | $1.76B |
| Total Current Assets | $278.31M | $256.42M | $221.89M | $227.26M | $227.26M |
| Cash and Cash Equivalents & Short-Term Investments | $90.01M | $69.71M | $51.23M | $58.83M | $58.83M |
| -Cash and Cash Equivalents | $90.01M | $69.71M | $51.23M | $58.83M | $58.83M |
| Receivables | $173.51M | $172.21M | $154.13M | $150.85M | $150.85M |
| -Accounts Receivable | $140.34M | $140.66M | $134.08M | $131.84M | $131.84M |
| -Other Receivables | $33.17M | $31.55M | $20.05M | $15.52M | $15.52M |
| Prepaid Assets | $14.79M | $14.50M | $16.53M | $17.58M | $17.58M |
| Total Non-Current Assets | $1.55B | $1.55B | $1.54B | $1.54B | $1.54B |
| Net PPE | $233.68M | $233.10M | $226.30M | $221.26M | $221.26M |
| -Gross PPE | $233.68M | $233.10M | $226.30M | $500.82M | $500.82M |
| Investments and Advances | $428.02M | $423.33M | $420.52M | $423.19M | $423.19M |
| -Long Term Equity Investment | $428.02M | $423.33M | $420.52M | $423.19M | $423.19M |
| Goodwill and Other Intangible Assets | $846.14M | $847.28M | $847.80M | $848.89M | $848.89M |
| -Goodwill | $807.55M | $807.55M | $807.55M | $807.55M | $807.55M |
| -Other Intangible Assets | $38.58M | $39.72M | $40.25M | $41.34M | $41.34M |
| Other Non-Current Assets | $46.99M | $48.65M | $46.85M | $43.95M | $43.95M |
| Total Liabilities | $1.20B | $1.19B | $1.16B | $1.18B | $1.18B |
| Total Current Liabilities | $183.46M | $178.36M | $157.93M | $179.19M | $179.19M |
| Payables | $27.60M | $33.61M | $41.55M | $49.19M | $49.19M |
| -Accounts Payable | $20.38M | $27.06M | $37.17M | $44.86M | $44.86M |
| -Total Tax Payable | $5.62M | $4.23M | $535,000.00 | $421,000.00 | $421,000.00 |
| -Other Payable | $1.60M | $2.32M | $3.85M | $3.91M | $3.91M |
| Current Accrued Expenses | $52.21M | $52.69M | $44.24M | $41.87M | $41.87M |
| Short-Term Debt and Capital Lease Obligation | $45.15M | $42.13M | $40.59M | $38.78M | $38.78M |
| -Current Debt | $17.87M | $15.60M | $15.13M | $14.71M | $14.71M |
| -Current Capital Lease Obligation | $27.28M | $26.53M | $25.46M | $24.07M | $24.07M |
| Total Non-Current Liabilities | $1.02B | $1.02B | $1.01B | $999.24M | $999.24M |
| Long Term Debt and Capital Lease Obligation | $931.68M | $933.23M | $926.86M | $923.73M | $923.73M |
| -Long Term Debt | $821.52M | $819.75M | $816.97M | $819.03M | $819.03M |
| -Long Term Capital Lease Obligation | $110.16M | $113.47M | $109.89M | $104.70M | $104.70M |
| Non-Current Deferred Liabilities | $47.04M | $43.59M | $41.50M | $40.77M | $40.77M |
| Other Non-Current Liabilities | $36.87M | $38.54M | $37.44M | $34.74M | $34.74M |
| Total Equity | $634.08M | $615.06M | $599.62M | $586.12M | $586.12M |
| Stockholders' Equity | $634.08M | $615.06M | $599.62M | $586.12M | $586.12M |
| Capital Stock | $96,000.00 | $96,000.00 | $96,000.00 | $96,000.00 | $96,000.00 |
| -Common Stock | $96,000.00 | $96,000.00 | $96,000.00 | $96,000.00 | $96,000.00 |
| Additional Paid-In Capital | $1.25B | $1.24B | $1.23B | $1.22B | $1.22B |
| Retained Earnings | -$619.42M | -$626.60M | -$629.34M | -$631.06M | -$631.06M |
| -Taxes Receivable | – | – | – | $3.50M | $3.50M |
| -Accumulated Depreciation | – | – | – | -$279.55M | -$279.55M |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | $34.81M | $32.80M | $2.93M | $17.07M | $17.10M |
| Net cash flow from continuing operations | $34.81M | $32.80M | $2.93M | $17.07M | $17.10M |
| Net Income from Continuing Operations | $7.18M | $2.75M | $1.72M | -$47.10M | -$28.69M |
| Gain/Loss from Continuing Operations | -$3.91M | $576,000.00 | $2.81M | -$2.72M | $5.42M |
| Depreciation & Depletion & Amortization | $14.25M | $14.08M | $13.88M | $55.39M | $16.24M |
| Deferred Tax | $3.45M | $2.09M | $726,000.00 | $8.08M | $4.57M |
| Other Non-Cash Items | $801,000.00 | $1.28M | $384,000.00 | $6.18M | $1.57M |
| Change in Working Capital | $432,000.00 | -$711,000.00 | -$28.86M | -$44.35M | -$581,000.00 |
| -Change in Receivables | -$1.30M | -$18.09M | -$3.28M | -$14.01M | -$1.50M |
| -Change in Prepaid Assets | -$940,000.00 | $1.46M | $1.57M | -$6.28M | $92,000.00 |
| -Change in Payables and Accrued Expense | $5.76M | $20.92M | -$21.44M | -$3.52M | $2.37M |
| -Change in Other Current Assets | $1.40M | -$2.03M | -$4.35M | -$13.30M | $3.80M |
| -Change in Other Current Liabilities | -$4.49M | -$2.99M | -$1.37M | -$7.24M | -$5.34M |
| Net cash flow from investing | -$14.05M | -$13.64M | -$5.27M | -$20.96M | -$2.40M |
| Net Cash Flow from Continuing Investing Activities | -$14.05M | -$13.64M | -$5.27M | -$20.96M | -$2.40M |
| Net PPE Purchase and Sale | -$14.05M | -$9.67M | -$5.27M | -$20.83M | -$2.40M |
| Net Intangibles Purchase and Sale | $0.00 | – | – | – | – |
| Net Business Purchase and Sale | $0.00 | – | – | -$123,000.00 | $0.00 |
| Financing Cash Flow | -$454,000.00 | -$685,000.00 | -$5.26M | $36.58M | $43.93M |
| Net Cash Flow from Continuing Financing Activities | -$454,000.00 | -$685,000.00 | -$5.26M | $36.58M | $43.93M |
| Net Issuance Payments Of Debt | -$786,000.00 | -$199,000.00 | -$5.26M | -$381.92M | -$373.74M |
| Net Common Stock Issuance | $332,000.00 | -$332,000.00 | $0.00 | $435.59M | $434.75M |
| Net Other Financing Charges | $0.00 | – | – | -$17.08M | – |
| Ending Cash Balance | $90.01M | $69.71M | $51.23M | $58.83M | $58.83M |
| Net Change in Cash | $20.31M | $18.48M | -$7.60M | $32.70M | $58.64M |
| Beginning Cash Balance | $69.71M | $51.23M | $58.83M | $26.13M | $191,000.00 |
| Free Cash Flow | $20.60M | $22.53M | -$2.38M | -$6.40M | $12.85M |
No comments yet — be the first to weigh in on LMRI.
Sign in to join the discussion.